Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Medtronic and OsteoGenix establish development agreement

March 23, 2007

Akesis in-licenses BEOV from U. of British Columbia

March 23, 2007

Radius' hPTHrP analogue begins phase II testing for osteoporosis

March 22, 2007

Recent patents cover new therapeutic agents for nutritional disorders such as obesity

March 21, 2007

Takeda warns on increased risk of fractures associated with pioglitazone

March 21, 2007

Enrollment completed in final phase III study for ferumoxytol

March 21, 2007

Enrollment completed in phase II trials for Amigal

March 20, 2007

Sanofi-aventis planning European launch of SoloSTAR disposable insulin pen

March 20, 2007

Soliris approved for paroxysmal nocturnal hemoglobinuria

March 19, 2007

First European launch for Dynepo

March 19, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...